切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2022, Vol. 16 ›› Issue (06) : 647 -650. doi: 10.3877/cma.j.issn.1674-3946.2022.06.017

论著

双示踪导航腹腔镜胃癌根治术的单臂开放前瞻性研究
刘颂1, 宋鹏1, 艾世超1, 杨志1, 王萌1, 陆晓峰1,(), 管文贤1,()   
  1. 1. 210008 南京,南京大学医学院附属鼓楼医院胃肠外科
  • 收稿日期:2021-10-30 出版日期:2022-12-26
  • 通信作者: 陆晓峰, 管文贤

Dual tracing navigation surgery for laparoscopic radical gastrectomy:a single arm,open-label,prospective clinical trial

Song Liu1, Peng Song1, Shichao Ai1, Zhi Yang1, Meng Wang1, Xiaofeng Lu1,(), Wenxian Guan1,()   

  1. 1. Department of Gastrointestinal Surgery,Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School,Nanjing Jiangsu Province 210008,China
  • Received:2021-10-30 Published:2022-12-26
  • Corresponding author: Xiaofeng Lu, Wenxian Guan
  • Supported by:
    National Natural Science Foundation of China(82172645); Natural Science Foundation of Jiangsu Province(BK20200052); Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University(2021-LCYJ-MS-09)
引用本文:

刘颂, 宋鹏, 艾世超, 杨志, 王萌, 陆晓峰, 管文贤. 双示踪导航腹腔镜胃癌根治术的单臂开放前瞻性研究[J/OL]. 中华普外科手术学杂志(电子版), 2022, 16(06): 647-650.

Song Liu, Peng Song, Shichao Ai, Zhi Yang, Meng Wang, Xiaofeng Lu, Wenxian Guan. Dual tracing navigation surgery for laparoscopic radical gastrectomy:a single arm,open-label,prospective clinical trial[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2022, 16(06): 647-650.

目的

探讨双示踪(吲哚菁绿联合纳米碳)导航在腹腔镜胃癌根治术中的安全性与有效性。

方法

开展单臂开放前瞻性临床研究,自2021年7月至2021年9月共纳入符合纳排标准的患者共15例,入组患者同时接受吲哚菁绿与纳米碳示踪,其中吲哚菁绿注射采用腹腔镜下浆膜面“六点法”,纳米碳注射采用胃镜下黏膜面“三明治法”,实施规范化D2腹腔镜胃癌根治术及标本淋巴结检取。15例患者中男性11例(73.3%),女性4例(26.7%),平均年龄(57.1±12.8)岁,腹腔镜根治性全胃切除术(π吻合)6例(40.0%)、腹腔镜根治性远端胃大部切除术(毕Ⅱ式+Braun吻合)9例(60.0%),分析手术时长、术中出血量、术后住院天数、并发症及二次手术率、存活率,术后病理分期、各站淋巴结检取数目及总数目。

结果

入选患者的平均手术时间(254.7±40.1)min,术中出血量(90.0±51.7)ml,术后住院天数(10.5±1.5)d,无严重并发症或非计划二次手术,至今均存活。各站淋巴结清扫数目不等,总清扫数为(44.6±13.1)枚。

结论

双示踪(吲哚菁绿联合纳米碳)导航在腹腔镜胃癌根治术中安全有效。

Objective

To investigate the safety and efficacy of double tracer(indocyanine green combined with carbon nanoparticles)navigation in laparoscopic radical gastrectomy for gastric cancer.

Methods

Prospective clinical study to carry out the single arm and opening up,from July 2021 to September 2021 were included in a total of 15 patients with na line standard,into the group of patients at the same time accept indocyanine green with nano carbon tracer,including indocyanine green injection by "six point method" laparoscopic serosal surface,nano carbon injection by "sandwich method",the mucosa under gastroscope surface Standardized D2 laparoscopic radical gastrectomy and lymph node sampling were performed. There were 11 males(73.3%)and 4 females(26.7%),with an average age of(57.1±12.8)years. There were 6 cases(40.0%)of laparoscopic radical total gastrectomy(π anastomosis)and 9 cases(60.0%)of laparoscopic radical distal subtotal gastrectomy(BiⅡ+Braun anastomosis). The operation time,intraoperative blood loss,postoperative hospital stay,complications,second operation rate,survival rate,postoperative pathological stage,the number of lymph nodes detected at each station and the total number were analyzed.

Results

The mean operation time was(254.7±40.1)min,intraoperative blood loss was(90.0±51.7)ml,and postoperative hospital stay was(10.5±1.5)days. There were no serious complications or unplanned reoperation. The total number of lymph nodes dissected was(44.6±13.1).

Conclusion

Dual tracer navigation(indocyanine green combined with carbon nanoparticles)is safe and effective in laparoscopic radical gastrectomy.

图1 双示踪导航腹腔镜胃癌根治术纳米碳注射方法(三明治法)注:A=胃镜示胃癌病灶;B=胃镜下于病灶口侧及肛侧黏膜下注射纳米碳
图2 双示踪导航腹腔镜胃癌根治术ICG注射方法(六点法)注:A=贲门下小弯侧;B=胃角小弯侧;C=胃窦小弯侧;D=贲门下大弯侧;E=胃角大弯侧;F=胃窦大弯侧
表1 双示踪(吲哚菁绿联合纳米碳)导航腹腔镜胃癌根治术各站淋巴结清扫数目[(
xˉ
±s),枚]
图3 双示踪导航腹腔镜胃癌根治术淋巴结检取情况
[1]
Chen QYXie JWZhong Q,et al. Safety and efficacy of indocyanine green tracer-guided lymph node dissection during laparoscopic radical gastrectomy in patients with gastric cancer:a randomized clinical trial[J]. JAMA Surgery2020155(4):300-311.
[2]
胡祥,张驰. 第15版日本《胃癌处理规约》拔萃[J]. 中国实用外科杂志201838(5):520-528.
[3]
中国抗癌协会胃癌专业委员会,中华医学会肿瘤学分会胃肠学组,中国医师协会外科医师分会肿瘤外科医师委员会. 胃癌根治术标本规范淋巴结送检及操作中国专家共识(2019版)[J]. 中国实用外科杂志201939(9):881-889.
[4]
黄昌明,陈起跃,刘治羽,等. 中国腹腔镜胃癌手术20年发展、问题与对策[J/CD]. 中华普外科手术学杂志(电子版)202115(2):123-128.
[5]
崔伟,李涛,李世拥. 中国腹腔镜胃癌手术20年历程与成就[J/CD]. 中华普外科手术学杂志(电子版)202115(2):139-142.
[6]
李子禹,吴舟桥,王一丁,等. 腹腔镜胃癌术后主要并发症防治策略[J/CD]. 中华普外科手术学杂志(电子版)202115(2):133-138.
[7]
Deng JYamashita HSeto Y,et al. Increasing the number of examined lymph nodes is a prerequisite for improvement in the accurate evaluation of overall survival of node-negative gastric cancer patients[J]. Annual of Surgical Oncology201724(3):745-753.
[8]
Deng JLiu JWang W,et al. Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American Joint Committee on Cancer(AJCC)TNM staging system[J]. Chin J Cancer Res201830(5):477-491.
[9]
刘乾,尹振宇,李晓梅,等. 吲哚菁绿在胃癌手术中的应用三例报道[J/CD]. 中华普外科手术学杂志(电子版)202115(2):235-236.
[10]
Lu XLiu SXia X,et al. The short-term and long-term outcomes of indocyanine green tracer-guided laparoscopic radical gastrectomy in patients with gastric cancer[J]. World J Surg Oncol202119(1):271.
[11]
洪强,汪勇,王建军,等. 术前胃镜下注射法纳米碳淋巴结示踪技术在腹腔镜胃癌根治术中的应用[J]. 中华医学杂志201797(2):123-126.
[12]
陆晓峰,刘颂,艾世超,等. 纳米碳导航3D腹腔镜胃癌根治术中淋巴结检取检取的临床价值探讨[J/CD]. 中华腔镜外科杂志(电子版)202013(6):352-356.
[13]
陆晓峰,刘颂,艾世超,等. 纳米碳与吲哚菁绿导航腹腔镜胃癌根治术淋巴结清扫的对比性研究[J/CD]. 中华普外科手术学杂志(电子版)202115(2):146-149.
[14]
朱煜,陈新华,李婷婷,等. 胃癌D2淋巴结清扫术后标本淋巴结分拣的经验分享[J]. 中华胃肠外科杂志201922(8):796-800.
[15]
邓靖宇,梁寒. 胃癌根治术后规范淋巴结送检的要点及临床意义[J]. 中华胃肠外科杂志201821(10):1183-1190.
[1] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[2] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[3] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[4] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[5] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[6] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[7] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[8] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[9] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[10] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[11] 李博, 贾蓬勃, 李栋, 李小庆. ERCP与LCBDE治疗胆总管结石继发急性重症胆管炎的效果[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 60-63.
[12] 韩戟, 杨力, 陈玉. 腹部形态CT参数与完全腹腔镜全胃切除术术中失血量的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 88-91.
[13] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[14] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[15] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?